1. Immediate Implant Reconstruction in Patients Undergoing Radiation Therapy: Opportunities and Challenges

   • Slava Agafonoff
   • Neilendu Kundu
   • Chirag Shah

   Breast Oncology 02 January 2020 Pages: 963 - 965

2. Underutilization of Enhanced Recovery After Surgery (ERAS) in Breast Surgery: An Opportunity to Reduce Opioid Usage

   • Amy E. Cyr

   Breast Oncology 23 January 2020 Pages: 966 - 968

3. Identifying Factors Predicting Long-Term Opioid Use After Mastectomy

   • Sarah M. DeSnyder

   Breast Oncology 05 February 2020 Pages: 969 - 970

4. Postoperative CEA and Other Non-traditional Risk Factors for Colon Cancer Recurrence: Findings from Swedish Population-Based Data

   • Mary R. Kwaan

   Colorectal Cancer 18 December 2019 Pages: 971 - 972

5. Exploring Microsatellite Instability (MSI) in Colorectal Cancer at Elevated Microsatellite Alterations at Selected Tetranucleotides (EMAST)

   • Vadim Kurbatov
   • Sajid A. Khan

   Translational Research and Biomarkers 01 December 2019 Pages: 973 - 974

6. Comment on “Diagnostic Laparoscopy as a Selection Tool for Patients with Colorectal Peritoneal Metastases to Prevent a Non-therapeutic Laparotomy During Cytoreductive Surgery”

   • Colette R. Pameijer

   Peritoneal Surface Malignancy 14 January 2020 Pages: 975 - 977

7. Artificial Intelligence in Cancer Staging: Limitless Potential or Passing Fad?

   • John W. Kunstman

   Hepatobiliary Tumors 03 January 2020 Pages: 978 - 979

8. Incidental Gallbladder Cancer: Permission to Operate

   • Suna Erdem
   • Rebekah R. White

   Hepatobiliary Tumors 13 November 2019 Pages: 980 - 982

9. Hypofractionated Radiation Therapy: A Potential Option for Advanced Intrahepatic Cholangiocarcinoma

   • Junichi Shindoh

   Hepatobiliary Tumors 17 December 2019 Pages: 983 - 984

10. Pain Control in Breast Surgery: Survey of Current Practice and Recommendations for Optimizing Management—American Society of Breast Surgeons Opioid/Pain Control Workgroup

    • Roshni Rao
    • Rubie Sue Jackson
    • the American Society of Breast Surgeons: Patient Safety & Quality Committee, Research Committee

    Breast Oncology 21 January 2020 Pages: 985 - 990

    

11. ASO Author Reflections: Overregulation Got Us into This, Only Letting Us Be Doctors Will Get Us Out

    • Roshni Rao
    • Joshua Froman

    ASO Author Reflections 05 February 2020 Pages: 991 - 992

12. Identifying Factors Predicting Prolonged Opioid Use After Mastectomy

    • Matthew R. Woeste
    • Neal Bhutiani
    • Nicolás Ajkay

    Breast Oncology 21 January 2020 Pages: 993 - 1001

13. Treatment and Prognosis of Radiation-Associated Breast Angiosarcoma in a Nationwide Population

    • Samuli H. Salminen
    • Tom Wiklund
    • Carl P. Blomqvist

    Breast Oncology Open access 26 November 2019 Pages: 1002 - 1010

    

14. ASO Author Reflections: Registry-Based Analysis of Radiation-Associated Angiosarcoma of the Breast Provides Unbiased Insights into this Disease

    • Samuli H. Salminen
    • Carl P. Blomqvist

    ASO Author Reflections Open access 12 December 2019 Pages: 1011 - 1012

15. Effect of Surgeon Factors on Long-Term Patient-Reported Outcomes After Breast-Conserving Therapy in Older Breast Cancer Survivors

    • Benjamin D. Smith
    • Xiudong Lei
    • Cameron W. Swanick

    Breast Oncology 08 January 2020 Pages: 1013 - 1022

    

16. ASO Author Reflections: Impact of Surgical Subspecialization in Breast Cancer—The Case for Fellowship Training

    • Kevin Diao
    • Benjamin D. Smith

    ASO Author Reflections 21 January 2020 Pages: 1023 - 1024

17. Primary Tumor Surgery for Patients with De Novo Stage IV Breast Cancer can Decrease Local Symptoms and Improve Quality of Life

    • Yiran Si
    • Peng Yuan
    • Binghe Xu

    Breast Oncology Open access 22 January 2020 Pages: 1025 - 1033

    

18. ASO Author Reflections: Effect of Primary Surgery on Quality of Life in De Novo Stage IV Breast Cancer Patients

    • Yiran Si
    • Peng Yuan

    ASO Author Reflections 07 February 2020 Pages: 1034 - 1035

19. Beyond the NCCN Risk Factors in Colon Cancer: An Evaluation in a Swedish Population-Based Cohort

    • Erik Osterman
    • Artur Mezheyeuski
    • Bengt Glimelius

    Colorectal Cancer Open access 01 January 2020 Pages: 1036 - 1045

    

20. ASO Author Reflections: Emerging Risk Factors in Colon Cancer—End of the Line for Clinomics?

    • Erik Osterman
    • Bengt Glimelius

    ASO Author Reflections Open access 28 December 2019 Pages: 1046 - 1047

21. Differences in Metastatic Pattern in Patients Presenting With or Without Obstructing Colorectal Cancer: A Retrospective Observational Study of 2595 Patients

    • Jeske R. E. Boeding
    • Winesh Ramphal
    • Jennifer M. J. Schreinemakers

    Colorectal Cancer 10 December 2019 Pages: 1048 - 1055

    

22. ASO Author Reflections: Patterns of Metastases in Patients with Obstructing Colorectal Cancer

    • Jeske R. E. Boeding
    • Jennifer M. J. Schreinemakers

    ASO Author Reflections 11 February 2020 Pages: 1056 - 1057

23. Elevated Microsatellite Alterations at Selected Tetranucleotides (EMAST) in Colorectal Cancer is Associated with an Elderly, Frail Phenotype and Improved Recurrence-Free Survival

    • Martin M. Watson
    • Arezo Kanani
    • Kjetil Søreide

    Translational Research and Biomarkers 04 November 2019 Pages: 1058 - 1067

    

24. Nicaraven Attenuates Postoperative Systemic Inflammatory Responses-Induced Tumor Metastasis

    • Xu Zhang
    • Takahito Moriwaki
    • Tao-Sheng Li

    Translational Research and Biomarkers Open access 23 December 2019 Pages: 1068 - 1074

    

25. ASO Author Reflections: How Should a Surgeon Care and Manage Cancer Metastasis?

    • Xu Zhang
    • Tao-Sheng Li

    ASO Author Reflections 12 December 2019 Pages: 1075 - 1076

26. Lymph Node Positivity in One-Step Nucleic Acid Amplification is a Prognostic Factor for Postoperative Cancer Recurrence in Patients with Stage II Colorectal Cancer: A Prospective, Multicenter Study

    • Michio Itabashi
    • Hirofumi Yamamoto
    • Nariaki Matsuura

    Translational Research and Biomarkers Open access 13 November 2019 Pages: 1077 - 1083

    

27. Diagnostic Laparoscopy as a Selection Tool for Patients with Colorectal Peritoneal Metastases to Prevent a Non-therapeutic Laparotomy During Cytoreductive Surgery

    • Judith E. K. R. Hentzen
    • Reickly D. N. Constansia
    • Schelto Kruijff

    Gastrointestinal Oncology Open access 22 October 2019 Pages: 1084 - 1093

28. Prophylactic HIPEC in pT4 Colon Tumors: Proactive Approach or Overtreatment?

    • Nerea Borda Arrizabalaga
    • José María Enriquez Navascués
    • Leyre Velaz Pardo

    Gastrointestinal Oncology Open access 29 October 2019 Pages: 1094 - 1100

29. Robotic Treatment for Large Duodenal Gastrointestinal Stromal Tumor

    • Alessandra Marano
    • Fabrizio Allisiardi
    • Felice Borghi

    Gastrointestinal Oncology 06 November 2019 Pages: 1101 - 1102

30. Four-Point Computed Tomography Scores for Evaluation of Occult Peritoneal Metastasis in Patients with Gastric Cancer: A Region-to-Region Comparison with Staging Laparoscopy

    • Zi-Yu Li
    • Lei Tang
    • Jia-Fu Ji

    Peritoneal Surface Malignancy Open access 21 January 2020 Pages: 1103 - 1109

    

31. A Machine-Based Approach to Preoperatively Identify Patients with the Most and Least Benefit Associated with Resection for Intrahepatic Cholangiocarcinoma: An International Multi-institutional Analysis of 1146 Patients

    • Diamantis I. Tsilimigras
    • Rittal Mehta
    • Timothy M. Pawlik

    Hepatobiliary Tumors 14 November 2019 Pages: 1110 - 1119

    

32. ASO Author Reflections: Use of Machine Learning to Identify Patients with Intrahepatic Cholangiocarcinoma Who Could Benefit More from Neoadjuvant Therapies

    • Diamantis I. Tsilimigras
    • Rittal Mehta
    • Timothy M. Pawlik

    ASO Author Reflections 11 November 2019 Pages: 1120 - 1121

33. Hypofractionated Radiation Therapy for Unresectable/Locally Recurrent Intrahepatic Cholangiocarcinoma

    • Alicia C. Smart
    • Lipika Goyal
    • Jennifer Y. Wo

    Hepatobiliary Tumors 23 December 2019 Pages: 1122 - 1129

    

34. ASO Author Reflections: High-Dose Radiation Offers Local Control for Inoperable Intrahepatic Cholangiocarcinoma

    • Alicia C. Smart
    • Jennifer Y. Wo

    ASO Author Reflections 19 December 2019 Pages: 1130 - 1131

35. Re-resection in Incidental Gallbladder Cancer: Survival and the Incidence of Residual Disease

    • Elise A. J. de Savornin Lohman
    • Lydia G. van der Geest
    • Philip R. de Reuver

    Hepatobiliary Tumors Open access 18 November 2019 Pages: 1132 - 1142

    

36. Laparoscopic Segment 1 with Partial IVC Resection in Advanced Cirrhosis: How to Do It Safely

    • Eduardo A. Vega
    • Diana C. Nicolaescu
    • Claudius Conrad

    Hepatobiliary Tumors 17 December 2019 Pages: 1143 - 1144

37. ASO Author Reflections: Laparoscopic Caudate Resection in Advanced Cirrhosis: Are We Transferring the Pain from the Patient to the Surgeon?

    • Eduardo A. Vega
    • Claudius Conrad

    ASO Author Reflections 13 January 2020 Pages: 1145 - 1146

    

38. The MEGNA Score and Preoperative Anemia are Major Prognostic Factors After Resection in the German Intrahepatic Cholangiocarcinoma Cohort

    • Andreas A. Schnitzbauer
    • Johannes Eberhard
    • Felix Rückert

    Hepatobiliary Tumors 23 October 2019 Pages: 1147 - 1155

    

39. Primary Liver Cancer: An NCDB Analysis of Overall Survival and Margins After Hepatectomy

    • Christopher Coon
    • Nicholas Berger
    • T. Clark Gamblin

    Hepatobiliary Tumors 01 November 2019 Pages: 1156 - 1163

    

40. KRAS Mutation Predicted More Mirometastases and Closer Resection Margins in Patients with Colorectal Cancer Liver Metastases

    • Qiongyan Zhang
    • Junjie Peng
    • Lei Wang

    Hepatobiliary Tumors 12 November 2019 Pages: 1164 - 1173

    

41. Robotic ALPPS

    • Marcel Autran C. Machado
    • Rodrigo C. Surjan
    • Fabio Makdissi

    Hepatobiliary Tumors 04 November 2019 Pages: 1174 - 1179

    

42. Survival Outcomes After Metastasectomy in Melanoma Patients Categorized by Response to Checkpoint Blockade

    • Danielle M. Bello
    • Katherine S. Panageas
    • Charlotte E. Ariyan

    Melanoma 17 December 2019 Pages: 1180 - 1188

    

43. ASO Author Reflections: Is There a Re-invigorated Role for Melanoma Metastasectomy in a Checkpoint Blockade Era?

    • Danielle M. Bello
    • Charlotte E. Ariyan

    ASO Author Reflections 17 January 2020 Pages: 1189 - 1190

44. Neoadjuvant Therapy is Associated with Improved Survival in Borderline-Resectable Pancreatic Cancer

    • Akhil Chawla
    • George Molina
    • Jiping Wang

    Pancreatic Tumors 04 December 2019 Pages: 1191 - 1200

    

45. ASO Author Reflections: Neoadjuvant Therapy for Pancreatic Cancer—Standard of Care or Still Worth Debating?

    • Akhil Chawla
    • Jiping Wang

    ASO Author Reflections 17 December 2019 Pages: 1201 - 1202

46. Trends in the Number of Lymph Nodes Evaluated Among Patients with Pancreatic Neuroendocrine Tumors in the United States: A Multi-Institutional and National Database Analysis

    • Kota Sahara
    • Diamantis I. Tsilimigras
    • Timothy M. Pawlik

    Pancreatic Tumors 14 December 2019 Pages: 1203 - 1212

    

47. ASO Author Reflections: Trends in the Number of Lymph Nodes Evaluated Following Resection of Pancreatic Neuroendocrine Tumors—An Increasing Adoption of the AJCC Guidelines?

    • Kota Sahara
    • Diamantis I. Tsilimigras
    • Timothy M. Pawlik

    ASO Author Reflections 12 December 2019 Pages: 1213 - 1214

48. Central Pancreatectomy Versus Distal Pancreatectomy and Pancreaticoduodenectomy for Benign and Low-Grade Malignant Neoplasms: A Retrospective and Propensity Score-Matched Study with Long-Term Functional Outcomes and Pancreas Volumetry

    • Doo-Ho Lee
    • Youngmin Han
    • Jin-Young Jang

    Pancreatic Tumors 02 January 2020 Pages: 1215 - 1224

    

49. ASO Author Reflections: Central Pancreatectomy Versus Distal Pancreatectomy and Pancreaticoduodenectomy for Benign or Low-Grade Malignant Neoplasms: A Propensity Score-Matched Study with Long-Term Functional Outcomes and Pancreas Volumetry

    • Doo-Ho Lee
    • Jin-Young Jang

    ASO Author Reflections 21 January 2020 Pages: 1225 - 1226

50. How Many Nodes Need to be Removed to Make Esophagectomy an Adequate Cancer Operation, and Does the Number Change When a Patient has Chemoradiotherapy Before Surgery?

    • Jonathan C. Yeung
    • Manjit S. Bains
    • Daniela Molena

    Thoracic Oncology 11 October 2019 Pages: 1227 - 1232